Healthcare

LTR Pharma Limited (ASX:LTP) is a clinical-stage pharmaceutical company focused on developing nasal spray drug delivery technologies. The company’s lead product, SPONTAN in Australia and ROXUS in the United States, is designed to deliver an established erectile dysfunction medicine through the nasal route. This …

Compumedics Limited (ASX:CMP) is an Australian medical technology company focused on sleep diagnostics, neurological monitoring and healthcare software solutions. The company develops systems used by healthcare providers to diagnose and monitor conditions affecting sleep and brain function. This article examines how Compumedics is expanding …

Mesoblast Limited (ASX:MSB) is a biotechnology company developing cell therapies for serious medical conditions. The company’s recent transition towards commercial activity has been centred on Ryoncil, a cell therapy approved in the United States for children with steroid-refractory acute graft-versus-host disease. This article examines …

Osteopore Limited (ASX:OSX) is a medical technology company developing 3D-printed bioresorbable implants that support bone regeneration. The company’s technology is designed to provide temporary scaffolds that allow natural bone growth before gradually being absorbed by the body. This article examines Osteopore’s technology platform, commercial …

Alterity Therapeutics Ltd (ASX:ATH) is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative diseases. Its lead programme, ATH434, is an investigational oral therapy being developed for multiple system atrophy (MSA), a rare and progressive neurological disorder. This article examines the clinical progress …

CONNEQT Health Limited (ASX:CQT) is an Australian cardiovascular technology company focused on developing connected health solutions. Formerly known as CardieX, the company uses its SphygmoCor technology platform to provide advanced cardiovascular measurements through connected devices. This article examines how CONNEQT is expanding beyond traditional …

Neuren Pharmaceuticals Limited (ASX:NEU) is an Australian biotechnology company focused on developing treatments for rare neurodevelopmental disorders. The company’s commercial foundation comes from DAYBUE (trofinetide), a therapy approved for Rett syndrome and licensed to a commercial partner. This article examines how royalty income supports …